We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan Races To Launch Generic Norvasc

Law360 (March 23, 2007, 12:00 AM EDT) -- Just a day after a court ruled its rival’s patent invalid, Mylan Laboratories has rushed to launch a generic version of Pfizer Inc’s blockbuster drug Norvasc.

With no time wasted, Mylan launched three strengths of its amlodipine besylate tablets Friday and triggered its 180-day exclusivity.

The pharmaceutical company was the first generic drug maker to file an application for a cheap version of Pfizer’s popular blood pressure drug.

Although it lost its patent challenge against Pfizer some months ago, a second attempt to challenge the patent...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.